At the time of writing, Dr. Reddy’s Laboratories Ltd. ADR [RDY] stock is trading at $13.71, up 0.96%. An important factor to consider is whether the stock is rising or falling in short-term value. The RDY shares have gain 8.12% over the last week, with a monthly amount glided 2.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] stock has seen the most recent analyst activity on December 19, 2024, when Nomura downgraded its rating to a Neutral. Previously, Jefferies downgraded its rating to Underperform on January 11, 2024. On August 29, 2023, downgrade downgraded it’s rating to Hold. Bernstein downgraded its rating to a Mkt Perform. BofA Securities upgraded its rating to a Buy. In a note dated November 14, 2022, Credit Suisse downgraded an Underperform rating on this stock.
For the past year, the stock price of Dr. Reddy’s Laboratories Ltd. ADR fluctuated between $12.50 and $16.89. Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] shares were valued at $13.71 at the most recent close of the market.
Analyzing the RDY fundamentals
According to Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY], the company’s sales were 3.72B for trailing twelve months, which represents an 14.24% jump. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.18 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.65 points at the first support level, and at 13.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.80, and for the 2nd resistance point, it is at 13.89.
Ratios To Look Out For
It is important to note that Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY] has a current ratio of 1.92. On the other hand, the Quick Ratio is 1.37, and the Cash Ratio is 0.09. Considering the valuation of this stock, the price to sales ratio is 3.07, the price to book ratio is 3.08 and price to earnings (TTM) ratio is 17.83.
Transactions by insiders
Recent insider trading involved Israeli Erez, Officer, that happened on Jul 29 ’24 when 65500.0 shares were purchased.
